Recombinant Human DEK Protein, His (Fc)-Avi-tagged

• Cat.No.: DEK-748H
• Product Overview: Recombinant Human DEK with His (Fc)-Avi tag was expressed and purified

Specification

• Source: HEK293
• Species: Human
• Tag: His&Fc&Avi
• Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method
• Purity: ≥85% by SDS-PAGE
• Stability: Stable for at least 6 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles.
• Storage: For long term storage, aliquot and store at -20 to -80 centigrade. Avoid repeated freezing and thawing cycles.
• Storage Buffer: PBS buffer

Gene Information

• Gene Name: DEK DEK proto-oncogene [ Homo sapiens (human) ]
• Official Symbol: DEK
• Synonyms: D6S231E
• Gene ID: 7913
• mRNA Refseq: NM_003472.4
• Protein Refseq: NP_003463.1
• MIM: 125264
• UniProt ID: P35659

Reviews

08/27/2021

This collaboration may extend beyond the purchase of the DEK protein, potentially leading to additional support, joint research projects, or access to expertise in the field.

12/20/2019

This may include providing detailed protocols, troubleshooting advice, and suggestions for experimental design.

08/13/2016

The manufacturer can provide researchers with high-quality DEK protein, ensuring it is properly purified, characterized, and quality-controlled.

Q&As

What are the current diagnostic methods for assessing DEK protein levels in clinical samples?

Enzyme-linked immunosorbent assay (ELISA) and immunohistochemistry are commonly used to measure DEK protein levels in clinical samples from cancer and autoimmune disease patients.

How does DEK protein contribute to the pathogenesis of autoimmune diseases?

DEK protein has been shown to play a role in aberrant immune responses, leading to the development of autoimmune diseases such as lupus and rheumatoid arthritis.

How does DEK protein interact with other cellular proteins in cancer and autoimmune diseases?

DEK protein has been shown to interact with various cellular proteins, modulating signaling pathways and gene expression patterns associated with cancer and autoimmune diseases.

Are there any specific genetic mutations associated with DEK protein dysregulation in cancer?

Mutations in the DEK gene and its regulatory regions have been identified in certain cancers, contributing to its aberrant expression and oncogenic potential.

Can DEK protein levels in patient samples predict treatment response in cancer therapy?

Studies have suggested that DEK protein levels in patient samples may serve as predictive biomarkers for treatment response and resistance in cancer therapy.